David Abraham - Net Worth and Insider Trading
David Abraham Net Worth
The estimated net worth of David Abraham is at least $3,562 dollars as of 2024-12-29. David Abraham is the GC, CCO & Corporate Secretary of Cartesian Therapeutics Inc and owns about 180 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $3,562. Details can be seen in David Abraham's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Abraham has not made any transactions after 2017-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Abraham
David Abraham Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Abraham owns 2 companies in total, including Cartesian Therapeutics Inc (RNAC) , and Gelesis Holdings Inc (GLSHQ) .
Click here to see the complete history of David Abraham’s form 4 insider trades.
Insider Ownership Summary of David Abraham
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2017-11-14 | Chief Comp Off & GC & Corp Sec |
| GLSHQ | Gelesis Holdings Inc | 2022-01-13 | Genrl Counsel & CCO & Secretary |
David Abraham Latest Holdings Summary
David Abraham currently owns a total of 1 stock. David Abraham owns 180 shares of Cartesian Therapeutics Inc (RNAC) as of November 14, 2017, with a value of $3,562.
Latest Holdings of David Abraham
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2017-11-14 | 180 | 19.79 | 3,562 |
Holding Weightings of David Abraham
David Abraham Form 4 Trading Tracker
According to the SEC Form 4 filings, David Abraham has made a total of 0 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years. The most-recent trade in Cartesian Therapeutics Inc is the acquisition of 180 shares on November 14, 2017, which cost David Abraham around $49,996.
Insider Trading History of David Abraham
- 1
David Abraham Trading Performance
GuruFocus tracks the stock performance after each of David Abraham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Abraham is -5.95%. GuruFocus also compares David Abraham's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Abraham within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Abraham's insider trading performs compared to the benchmark.
Performance of David Abraham
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.03 | | | | | |
| Relative Return to S&P 500(%) | 4.19 | | | | | |
David Abraham Ownership Network
David Abraham Owned Company Details
What does Cartesian Therapeutics Inc do?
Who are the key executives at Cartesian Therapeutics Inc?
David Abraham is the Chief Comp Off & GC & Corp Sec of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .
Cartesian Therapeutics Inc (RNAC) Insider Trades Summary
Over the past 18 months, David Abraham made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,921,182 shares made by Timothy A Springer , a net sale of 52,115 shares made by , and a net purchase of 7,500 shares made by Timothy C Barabe .
In summary, during the past 3 months, insiders sold 241,836 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 689,850 shares, with a net purchase of 448,014 shares. During the past 18 months, 241,957 shares of Cartesian Therapeutics Inc (RNAC) were sold and 746,143 shares were bought by its insiders, resulting in a net purchase of 504,186 shares.
Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cartesian Therapeutics Inc Insider Transactions
David Abraham Mailing Address
Above is the net worth, insider trading, and ownership report for David Abraham. You might contact David Abraham via mailing address: 480 Arsenal St., Building One, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
